JAMA Internal Medicine on the role of PrEP in ending the HIV epidemic
November 20, 2019
Two commentaries from JAMA Internal Medicine released this week focus on the role of PrEP in ending the HIV epidemic in the US. A special communication on the role of primary care clinicians in prescribing PrEP issues a “call for wider adoption of PrEP prescribing activities by frontline primary care clinicians.” The authors conclude, “For PCPs, the message is a simple one: TDF/FTC PrEP is safe and easy to prescribe. As the front line of health care, PCPs play a pivotal role in assessing all patients for their risk for HIV infection and deploying PrEP in clinically and epidemiologically appropriate individuals. The primary care community is the cornerstone of ending the HIV epidemic.”
An editors note on the role of increased testing and PrEP argues that “self-testing kits targeting individuals at high risk of acquiring HIV complement the use of PrEP, and are another way to accelerate the end of the epidemic.”
For full text of both follow the links below.